Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Public ClinicalTrials.gov record NCT07282743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of GL0034 Among Type II Diabetes Mellitus Subjects Who Are Obese or Overweight With Weight-related Comorbidities
Study identification
- NCT ID
- NCT07282743
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Industry
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Interventions
- GL0034 Dose Level 1 Drug
- GL0034 Dose Level 2 Drug
- GL0034 Dose Level 3 Drug
- GL0034 Dose Level 4 Drug
- GL0034 Dose Level 5 Drug
- GL0034 Dose Level 6 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2026
- Primary completion
- Mar 31, 2027
- Completion
- Jul 31, 2027
- Last update posted
- Mar 17, 2026
2026 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lynn Institute of the Ozarks | Little Rock | Arkansas | 72204 | Recruiting |
| Family First Medical Research Center | Hialeah Gardens | Florida | 33175 | Recruiting |
| Alliance for Multispecialty Research (AMR Clinical) - Wichita East | Lakeland | Florida | 33803 | Recruiting |
| CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis) | Lakeland | Florida | 33803 | Recruiting |
| GTL Medical & Research Group | Miami | Florida | 33173 | Recruiting |
| Florida Institute for Clinical Research LLC | Orlando | Florida | 32835 | Recruiting |
| AMR Clinical, El Dorado | El Dorado | Kansas | 67042 | Recruiting |
| AMR Clinical - Newton | Newton | Kansas | 67114 | Recruiting |
| Lynn Health Science Institute - Oklahoma City | Oklahoma City | Oklahoma | 73112 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07282743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2026 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07282743 live on ClinicalTrials.gov.